menu
    • menu

    Company profile for Enalare Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Enalare Therapeutics Inc. is a clinical stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term. There is an...
    Enalare Therapeutics Inc. is a clinical stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term. There is an urgent need to develop novel agnostic therapeutic breathing stimulants to help patients suffering from acute respiratory depression.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Enalare TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Princeton, New Jersey 08540
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://enalare.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/enalare-therapeutics-inc/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    US FDA grants orphan drug designation to Enalare’s ENA-001
    US FDA grants orphan drug designation to Enalare’s ENA-001

    06 Oct 2022

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=153666&sid=2

    PHARMABIZ
    06 Oct 2022
    Share Share
    Eagle and Enalare Therapeutics Announce FDA Orphan Drug Designation for ENA-001
    Eagle and Enalare Therapeutics Announce FDA Orphan Drug Designation for ENA-001

    03 Oct 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/10/03/2526635/0/en/Eagle-Pharmaceuticals-and-Enalare-Therapeutics-Announce-FDA-Orphan-Drug-Designation-for-ENA-001-for-the-Treatment-of-Apnea-of-Prematurity-a-New-Chemical-Entity-Being-Developed-as-a.html

    GLOBENEWSWIRE
    03 Oct 2022
    Share Share
    New Jersey biotech nets $50M+ BARDA contract for respiratory candidate
    New Jersey biotech nets $50M+ BARDA contract for respiratory candidate

    27 Sep 2022

    // Tyler Patchen ENDPTS

    https://endpts.com/new-jersey-biotech-nets-50m-barda-contract-for-respiratory-candidate/

    Tyler Patchen ENDPTS
    27 Sep 2022
    Share Share
    Eagle Pharma Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics
    Eagle Pharma Takes Equity Stake in, with Option to Acquire, Enalare Therapeutics

    09 Aug 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/08/09/2494636/0/en/Eagle-Pharmaceuticals-Takes-Equity-Stake-in-with-Option-to-Acquire-Enalare-Therapeutics-to-Advance-Global-Development-of-ENA-001-a-Novel-Agnostic-Respiratory-Stimulant.html

    GLOBENEWSWIRE
    09 Aug 2022
    Share Share
    NIH Grants $2.8m to Help Startup Advance Second-Generation Breathing Stimulant
    NIH Grants $2.8m to Help Startup Advance Second-Generation Breathing Stimulant

    03 Jul 2022

    // TRIALSITENEWS

    https://www.trialsitenews.com/a/nih-grants-2.8m-to-help-startup-advance-second-generation-breathing-stimulant-to-combat-opioidpolysubstance-respiratory-depression-8386f30e

    TRIALSITENEWS
    03 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search